Showing 5,804 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Climate change

HIV treatment adherence may be another casualty of climate change

News
8 July 2022
The search for a cure

People Who Start HIV Treatment With High CD4s Have a Smaller Viral Reservoir

Editor's pick
POZ
7 July 2022
New & experimental HIV treatments

Fostemsavir Plus Optimized Background Therapy May Be Viable for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
30 June 2022
New & experimental HIV treatments

Gilead Resubmits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitor

Editor's pick
Gilead Sciences press release
28 June 2022
Injectable & long-acting HIV treatment

Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV

Editor's pick
Gilead Sciences press release
25 June 2022
Improving HIV care

How PEPFAR countries sustained HIV programmes in 2020 amidst COVID-19

News
22 June 2022
Weight gain & lipodystrophy

Substantial weight gain as dolutegravir is rolled out in Africa

News
21 June 2022
Cardiovascular disease

Integrase inhibitors raise the risk of heart attack, stroke during first two years of treatment

News
14 June 2022
New & experimental HIV treatments

Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120

Editor's pick
GlobeNewswire (press release)
13 June 2022
Treatment guidelines

World’s largest HIV treatment programme could shift almost entirely to WHO-preferred first line regimen

News
7 June 2022
The search for a cure

Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period

Editor's pick
HIV.gov
6 June 2022
Resistance

Dolutegravir resistance showing up after prolonged periods on failing treatment

News
2 June 2022
Treatment guidelines

South Africa: Over 3 million people on new HIV drug, but not all smooth sailing

Editor's pick
Spotlight
1 June 2022
Drug interactions & pharmacokinetics

ViiV Healthcare has obtained marketing approval for the first and only complete long-acting treatment for HIV in Japan

Editor's pick
ViiV press release
31 May 2022
Adherence

Ingestible sensor helps identify PrEP adherence patterns

Editor's pick
Healio
30 May 2022
Health problems & ageing

Which health conditions are more or less common in people with HIV?

News
30 May 2022
Diabetes

Women with HIV at greater risk of diabetes than men

News
19 May 2022
Diabetes

Obesity more important than integrase inhibitors in risk for developing diabetes in people with HIV

News
19 May 2022
HIV treatment for children & young people

HHS Updates Pediatric HIV Guidelines

Editor's pick
Infectious Disease Special Edition
18 May 2022
New & experimental HIV treatments

FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV

Editor's pick
Gilead Sciences press release
18 May 2022
Cancer

Full-Dose Chemotherapy Regimen Appears Safe for Patients With HIV and Cancer

Editor's pick
Oncology Nurse Advisor
16 May 2022
Antibody-based treatment

Repeated infusions of two antibodies delay viral rebound but don’t prevent it

News
13 May 2022
Treatment guidelines

BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 - consultation open

Editor's pick
British HIV Association (BHIVA)
10 May 2022
Weight gain & lipodystrophy

High rates of obesity among middle-aged Black women with HIV in UK cohort

News
10 May 2022